hVIVO plc Award of Share Options (2330M)

TIDMHVO

RNS Number : 2330M

hVIVO plc

04 January 2019

hVIVO PLC

("hVIVO" or the "Company")

Award of Share Options

London, UK, 4 January 2019: hVIVO plc (AIM: HVO), an industry leading clinical development services business pioneering human disease models based upon viral and allergen challenge, announces that on 1st January 2019 it awarded the following options over ordinary shares of 5.0p each in the Company to Shelley Fraser:

 
 Name              Position            Number      Exercise     Date of     Percentage 
                                        of Share    price        Vesting     of issued 
                                        Options     per Share                ordinary 
                                        Awarded                              share capital 
                   Finance Director                             1 January 
 Shelley Fraser     (PDMR)              250,000       5.0p         2022          0.1% 
                  ------------------  ----------  -----------  ----------  --------------- 
 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail:

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the persons discharging managerial responsibilities/persons 
       closely associated 
 a)   Name                      Shelley Fraser 
     ------------------------  ----------------------------------------------- 
 2    Reason for the notification 
     ------------------------------------------------------------------------- 
 a)   Position/                 Finance Director (PDMR) 
       status 
     ------------------------  ----------------------------------------------- 
 b)   Initial notification/     Initial Notification 
       Amendment 
     ------------------------  ----------------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------------- 
 a)   Name                      hVIVO plc 
     ------------------------  ----------------------------------------------- 
 b)   Legal Entity              N/A 
       Identifier 
     ------------------------  ----------------------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------------- 
 a)   Description               Options over Ordinary Shares of 5 pence 
       of the financial          each 
       instrument, 
       type of instrument 
       Identification            ISIN: GB00B6ZM0X53 
       code 
     ------------------------  ----------------------------------------------- 
 b)   Nature of                 Award of options over ordinary shares in 
       the transaction           the Company 
     ------------------------  ----------------------------------------------- 
 c)   Currency                  GBP 
     ------------------------  ----------------------------------------------- 
 d)   Price(s) and                 PDMR              Exercise Price   Volume 
       volume(s)                                                (p) 
                                   Shelley Fraser    5.0              250,000 
                                                    ---------------  -------- 
     ------------------------ 
 
 e)   Aggregated 
       information 
       - Aggregated               Options over 250,000 ordinary shares 
       volume                     5.0p 
       - Exercise 
       price 
     ------------------------  ----------------------------------------------- 
 f)   Date of the               1st January 2019 
       transaction 
     ------------------------  ----------------------------------------------- 
 g)   Place of the              London Stock Exchange, AIM 
       transaction 
     ------------------------  ----------------------------------------------- 
 

For further information please contact:

 
 hVIVO plc                                                [phone] 
 Trevor Phillips (Executive Chairman) 
 Fleur Wood (Director, Investor Relations) 
 Numis Securities Limited                                  [phone] 
 Michael Meade / Freddie Barnfield (Nominated Adviser) 
 James Black / Michael Burke (Corporate Broking) 
 
 FTI Consulting                                           [phone] 
 Simon Conway / Victoria Foster Mitchell 
 

Notes to Editors:

hVIVO plc ("hVIVO") is pioneering a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases. Leveraging human disease models in flu, RSV, HRV and respiratory indications, the hVIVO platform captures disease in motion, illuminating the entire disease life cycle from healthy to sick and back to health. Based in the UK, market leader hVIVO has conducted more than 50 clinical studies and inoculated over 2500 volunteers.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHUSVKRKKAARRR

(END) Dow Jones Newswires

January 04, 2019 05:02 ET (10:02 GMT)